Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.42 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.42 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.38 |
| ▸ | KDM4A | O75164 | 2/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.38 |
| ▸ | TET3 | O43151 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | GABRP | O00591 | 2/20 | 0.37 |
| ▸ | GABRD | O14764 | 2/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL200455 | 0.83 | PLA2G2C (0.40) | FOLH1NAALAD2RIMKLATET2KDM4A | |
| SCHEMBL4461170 | 0.83 | LMNA (0.39) | FOLH1NAALAD2RIMKLATET2KDM4A | |
| SCHEMBL10617023 | 0.83 | PLA2G2C (0.40) | FOLH1NAALAD2RIMKLATET2KDM4A | |
| SCHEMBL28779839 | 0.80 | PLA2G2C (0.39) | FOLH1NAALAD2RIMKLAKDM2ACYP1A2 | |
| SCHEMBL3940840 | 0.80 | CTSC (0.41) | FOLH1NAALAD2RIMKLAKDM2ACYP2D6 | |
| SCHEMBL27880264 | 0.80 | FOLH1 (0.37) | FOLH1NAALAD2RIMKLATET2KDM4A | |
| SCHEMBL25183394 | 0.79 | PLA2G2C (0.49) | FOLH1CYP2D6NFKB1LMNAMAPT | |
| SCHEMBL25186456 | 0.79 | PLA2G2C (0.49) | FOLH1CYP2D6NFKB1LMNAMAPT | |
| SCHEMBL21724390 | 0.79 | PLA2G2C (0.45) | FOLH1NAALAD2RIMKLACYP1A2GABRP | |
| SCHEMBL25173449 | 0.79 | PLA2G2C (0.49) | FOLH1CYP2D6NFKB1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4212546-A1 | METHODS OF PRODUCING LONG ACTING CTP-MODIFIED POLYPEPTIDES | OPKO Biologics Ltd. (IL) | 2023-07-19 | — | — | EP | disclosed |
| US-20220170005-A1 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | OPKO BIOLOGICS LTD. (IL) | 2022-06-02 | — | — | US | disclosed |
| EP-3988113-A1 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | OPKO Biologics Ltd. (IL) | 2022-04-27 | — | — | EP | disclosed |
| US-20220000990-A1 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | OPKO BIOLOGICS LTD. (IL) | 2022-01-06 | — | — | US | disclosed |
| US-20210371487-A1 | METHODS OF PRODUCING LONG ACTING CTP-MODIFIED POLYPEPTIDES | OPKO BIOLOGICS LTD. (IL) | 2021-12-02 | — | — | US | disclosed |
| CN-113289009-A | Long-acting coagulation factor and production method thereof | OPKO生物科学有限公司 | 2021-08-24 | — | — | CN | disclosed |
| WO-2021154414-A2 | GENE THERAPY FOR HEMOPHILIA B WITH A CHIMERIC AAV CAPSID VECTOR ENCODING MODIFIED FACTOR IX POLYPEPTIDES | CATALYST BIOSCIENCES, INC. (US) | 2021-08-05 | — | — | WO | disclosed |
| EP-3310347-B1 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | OPKO BIOLOGICS LTD (IL) | 2021-08-04 | — | — | EP | disclosed |
| US-11066658-B2 | Long-acting coagulation factors and methods of producing same | OPKO BIOLOGICS LTD. (IL) | 2021-07-20 | — | — | US | disclosed |
| CN-108289851-B | Long-acting coagulation factor and production method thereof | OPKO生物科学有限公司 | 2021-06-01 | — | — | CN | disclosed |
| WO-1996040743-A2 | INHIBITORS OF FACTOR Xa | COR THERAPEUTICS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040744-A1 | KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa | COR THERAPEUTICS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-5583107-A | ACYLATED BLOOD FACTOR XA AS TREATMENT FOR HEMOPHILIA | COR THERAPEUTICS, INC. (US) | 1996-12-10 | — | — | US | disclosed |
| WO-1996013274-A1 | PROCESS FOR PRODUCTION OF INHIBITED FORMS OF ACTIVATED BLOOD FACTORS | COR THERAPEUTICS, INC. (US) | 1996-05-09 | — | — | WO | disclosed |
| WO-1996000577-A1 | AGENTS AFFECTING THROMBOSIS HEMOSTASIS | COR THERAPEUTICS, INC. (US) | 1996-01-11 | — | — | WO | disclosed |
| EP-0547180-A4 | RECOMBINANT AGENTS AFFECTING THROMBOSIS | COR THERAPEUTICS INC (US) | 1994-11-23 | — | — | EP | disclosed |
| US-5278144-A | Antithrombosis agents | COR THERAPEUTICS, INC. (US) | 1994-01-11 | — | — | US | disclosed |
| EP-0547180-A1 | RECOMBINANT AGENTS AFFECTING THROMBOSIS | COR THERAPEUTICS, INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| WO-1992004378-A1 | RECOMBINANT AGENTS AFFECTING THROMBOSIS | COR THERAPEUTICS, INC. (US) | 1992-03-19 | — | — | WO | disclosed |
| WO-1991009953-A1 | METHODS FOR PRODUCING HYBRID PHOSPHOLIPID-BINDING PROTEINS | ZYMOGENETICS, INC. (US) | 1991-07-11 | — | — | WO | disclosed |